Search Results for author:
Found 3 papers, 1 papers with code
MFBind: a Multi-Fidelity Approach for Evaluating Drug Compounds in Practical Generative Modeling
Current generative models for drug discovery primarily use molecular docking to evaluate the quality of generated compounds.
Target-Free Compound Activity Prediction via Few-Shot Learning
Predicting the activities of compounds against protein-based or phenotypic assays using only a few known compounds and their activities is a common task in target-free drug discovery.
LIMO: Latent Inceptionism for Targeted Molecule Generation
We corroborate these docking-based results with more accurate molecular dynamics-based calculations of absolute binding free energy and show that one of our generated drug-like compounds has a predicted $K_D$ (a measure of binding affinity) of $6 \cdot 10^{-14}$ M against the human estrogen receptor, well beyond the affinities of typical early-stage drug candidates and most FDA-approved drugs to their respective targets.
Cannot find the paper you are looking for? You can
Submit a new open access paper.
